Modeling malaria in humanized mice: Opportunities and challenges

Annals of the New York Academy of Sciences

Volumn 1342, Issue 1, 2015, Pages 29-36

  Siu, Evelyn ^a   Ploss, Alexander ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

Humanized mice; Malaria, Plasmodium falciparum

Indexed keywords

ANIMAL TISSUE; ARTICLE; DISEASE MODEL; HUMAN; IN VIVO STUDY; LIVER DEVELOPMENT; MALARIA; MOUSE; NONHUMAN; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM FALCIPARUM; ANIMAL; DRUG DEVELOPMENT; GENETICS; MALARIA FALCIPARUM; PATHOLOGY; TRANSGENIC MOUSE; TRENDS;

ANIMALIA; MAMMALIA; MUS; PLASMODIUM FALCIPARUM;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; HUMANS; MALARIA, FALCIPARUM; MICE; MICE, TRANSGENIC; PLASMODIUM FALCIPARUM;

EID: 84927909866     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12618     Document Type: Article

References (43)

1. WHO. 2013. World Malaria Report 2013.
2. CDC. About Malaria - Disease, Vol. 2014. Cited November 5, 2014. http://www.cdc.gov/malaria/about/disease.html.
3. Clyde, D.F. et al. 1973. Immunization of man against sporozite-induced Falciparum malaria. Am. J. Med. Sci. 266: 169-177.
4. Seder, R.A. et al. 2013. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341: 1359-1365.
5. Agnandji, S.T. et al. 2012. A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 367: 2284-2295.
6. Mota, M.M. et al. 2001. Migration of Plasmodium sporozoites through cells before infection. Science 291: 141-144.
7. Sturm, A. et al. 2006. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313: 1287-1290.
8. Krotoski, W.A. et al. 1982. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am. J. Trop. Med. Hyg. 31: 1291-1293.
9. Kitchen, S. 1938. The infection of reticulocytes by Plasmodium vivax. Am. J. Trop. Med. Hyg. 18: 347-353.
10. Miller, L.H. et al. 2002. The pathogenic basis of malaria. Nature 415: 673-679.
11. Beier, J.C. 1998. Malaria parasite development in mosquitoes. Annu. Rev. Entomol. 43: 519-543.
12. Walliker, D. et al. 1987. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 236: 1661-1666.
13. Collins, W.E. et al. 2009. Transmission of different strains of Plasmodium cynomolgi to Aotus Nancymaae monkeys and relapse. J. Parasitol. 95: 349-352.
14. Wadman, M. 2011. US chimpanzee research to be curtailed, Vol. 2014. Cited November 5, 2014. http://www.nature.com/news/us-chimpanzee-research-to-be-curtailed-1.9663.
15. Stephens, R., R.L. Culleton & T.J. Lamb. 2012. The contribution of Plasmodium chabaudi to our understanding of malaria. Trends Parasitol. 28: 73-82.
16. Sack, B.K. et al. 2014. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect. Immun. 82: 808-817.
17. Hall, N. et al. 2005. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 307: 82-86.
18. Mazier, D., L. Renia & G. Snounou. 2009. A pre-emptive strike against malaria's stealthy hepatic forms. Nat. Rev. Drug Discov. 8: 854-864.
19. Karnasuta, C. et al. 1995. Complete development of the liver stage of Plasmodium falciparum in a human hepatoma cell line. Am. J. Trop. Med. Hyg. 53: 607-611.
20. Dembele, L. et al. 2014. Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures. Nat. Med. 20: 307-312.
21. March, S. et al. 2013. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe 14: 104-115.
22. Shlomai, A. et al. 2014. Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems. Proc. Natl. Acad. Sci. U.S.A. 111: 12193-12198.
23. Schwartz, R.E. et al. 2012. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A. 109: 2544-2548.
24. Wu, X. et al. 2012. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog. 8: e1002617.
25. Billerbeck, E., Y. de Jong, M. Dorner, et al. 2013. Animal models for Hepatitis C. In Current Topics in Microbiology and Immunology, Vol. 369. R. Bartenschlager, Ed. Heidelberg: Springer.
26. Sandgren, E.P., R.D. Palmiter, J.L. Heckel et al. 1991. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell Host Microbe 66: 245-256.
27. Sacci, J.B., Jr. et al. 2006. Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. Int. J. Parasitol. 36: 353-360.
28. Heckel, J.L., E.P. Sandgren, J.L. Degen et al. 1990. Neonatal bleeding in transgenic mice expressing urokinase-type Plasminogen activator. Cell Host Microbe 62: 447-456.
29. Tesfaye, A. et al. 2013. Chimeric mouse model for the infection of hepatitis B and C viruses. PLoS One 8: e77298.
30. Hasegawa, M. et al. 2011. The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem. Biophys. Res. Commun. 405: 405-410.
31. Grompe, M. et al. 1993. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev. 7: 2298-2307.
32. -/- mice. Nat. Biotechnol. 25: 903-910.
33. Vaughan, A.M. et al. 2012. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J. Clin. Invest. 122: 3618-3628.
34. Strowig, T. et al. 2011. Transgenic expression of human signal regulatory protein alpha in Rag2(-/-)gamma(-/-)(c) mice improves engraftment of human hematopoietic cells in humanized mice. Proc. Natl. Acad. Sci. U.S.A. 108: 13218-13223.
35. Moore, J.M. et al. 1995. Maintenance of the human malarial parasite, Plasmodium falciparum, in scid mice and transmission of gametocytes to mosquitos. J. Exp. Med. 181: 2265-2270.
36. Angulo-Barturen, I. et al. 2008. A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. PLoS One 3: e2252.
37. Jimenez-Diaz, M.B. et al. 2009. Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rγ(null) mice engrafted with human erythrocytes. Antimicrob. Agents Ch. 53: 4533-4536.
38. Arnold, L. et al. 2011. Further improvements of the P. falciparum humanized mouse model. PLoS One 6: e18045.
39. Rongvaux, A. et al. 2013. Human hemato-lymphoid system mice: current use and future potential for medicine. Ann. Rev. Immunol. 31: 635-674.
40. Rongvaux, A. et al. 2011. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc. Natl. Acad. Sci. U.S.A. 108: 2378-2383.
41. Hu, Z., N.Van Rooijen & Y.G. Yang. 2011. Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood 118: 5938-5946.
42. Chen, Q., M. Khoury & J. Chen. 2009. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc. Natl. Acad. Sci. U.S.A. 106: 21783-21788.
43. Hunt, N.H. et al. 2010. Murine cerebral malaria: the whole story. Trends Parasitol. 26: 272-274.